These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8702597)

  • 1. Role of the C terminus of the interleukin 8 receptor in signal transduction and internalization.
    Prado GN; Suzuki H; Wilkinson N; Cousins B; Navarro J
    J Biol Chem; 1996 Aug; 271(32):19186-90. PubMed ID: 8702597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of chemokine-induced actin polymerization in undifferentiated human leukemia cells (HL-60) by heterologous expression of interleukin-8 receptors.
    Norgauer J; Metzner B; Czech W; Schraufstatter I
    Inflamm Res; 1996 Mar; 45(3):127-31. PubMed ID: 8689391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXC chemokines bind to unique sets of selectivity determinants that can function independently and are broadly distributed on multiple domains of human interleukin-8 receptor B. Determinants of high affinity binding and receptor activation are distinct.
    Ahuja SK; Lee JC; Murphy PM
    J Biol Chem; 1996 Jan; 271(1):225-32. PubMed ID: 8550564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
    Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
    Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-8 (IL-8), melanoma growth-stimulatory activity, and neutrophil-activating peptide selectively mediate priming of the neutrophil NADPH oxidase through the type A or type B IL-8 receptor.
    Green SP; Chuntharapai A; Curnutte JT
    J Biol Chem; 1996 Oct; 271(41):25400-5. PubMed ID: 8810307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activity of the growth factor-induced cytokine N51: structure-function analysis using N51/Interleukin-8 chimeric molecules.
    Heinrich JN; O'Rourke EC; Chen L; Gray H; Dorfman KS; Bravo R
    Mol Cell Biol; 1994 May; 14(5):2849-61. PubMed ID: 8164648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional and ligand binding specificity of the rabbit neutrophil IL-8 receptor.
    Thomas KM; Taylor L; Prado G; Romero J; Moser B; Car B; Walz A; Baggiolini M; Navarro J
    J Immunol; 1994 Mar; 152(5):2496-500. PubMed ID: 8133060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diverging signal transduction pathways activated by interleukin-8 and related chemokines in human neutrophils: interleukin-8, but not NAP-2 or GRO alpha, stimulates phospholipase D activity.
    L'Heureux GP; Bourgoin S; Jean N; McColl SR; Naccache PH
    Blood; 1995 Jan; 85(2):522-31. PubMed ID: 7812007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRObeta, GROgamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor.
    Ahuja SK; Murphy PM
    J Biol Chem; 1996 Aug; 271(34):20545-50. PubMed ID: 8702798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell migratory response to interleukin-8 is mediated through interaction with chemokine receptor CXCR2/Interleukin-8RB.
    Nilsson G; Mikovits JA; Metcalfe DD; Taub DD
    Blood; 1999 May; 93(9):2791-7. PubMed ID: 10216072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A His19 to Ala mutant of melanoma growth-stimulating activity is a partial antagonist of the CXCR2 receptor.
    Baly DL; Horuk R; Yansura DG; Simmons LC; Fairbrother WJ; Kotts C; Wirth CM; Gillece-Castro BL; Toy K; Hesselgesser J; Allison DE
    J Immunol; 1998 Nov; 161(9):4944-9. PubMed ID: 9794430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N51 competes 125I-interleukin (IL)-8 binding to IL-8R beta but not IL-8R alpha. Structure-function analysis using N51/IL-8 chimeric molecules.
    Heinrich JN; Bravo R
    J Biol Chem; 1995 Nov; 270(47):28014-7. PubMed ID: 7499284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchanging interleukin-8 and melanoma growth-stimulating activity receptor binding specificities.
    Lowman HB; Slagle PH; DeForge LE; Wirth CM; Gillece-Castro BL; Bourell JH; Fairbrother WJ
    J Biol Chem; 1996 Jun; 271(24):14344-52. PubMed ID: 8662882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoattractant cross-desensitization of the human neutrophil IL-8 receptor involves receptor internalization and differential receptor subtype regulation.
    Sabroe I; Williams TJ; Hébert CA; Collins PD
    J Immunol; 1997 Feb; 158(3):1361-9. PubMed ID: 9013980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and functional activity of the IL-8 receptor type CXCR1 and CXCR2 on human mast cells.
    Lippert U; Artuc M; Grützkau A; Möller A; Kenderessy-Szabo A; Schadendorf D; Norgauer J; Hartmann K; Schweitzer-Stenner R; Zuberbier T; Henz BM; Krüger-Krasagakes S
    J Immunol; 1998 Sep; 161(5):2600-8. PubMed ID: 9725262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma growth stimulatory activity enhances the phosphorylation of the class II interleukin-8 receptor in non-hematopoietic cells.
    Mueller SG; Schraw WP; Richmond A
    J Biol Chem; 1994 Jan; 269(3):1973-80. PubMed ID: 8294449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor binding specificity and pulmonary gene expression of the neutrophil-activating peptide ENA-78.
    Bozic CR; Gerard NP; Gerard C
    Am J Respir Cell Mol Biol; 1996 Mar; 14(3):302-8. PubMed ID: 8845182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure and activity of a chimeric interleukin-8-melanoma-growth-stimulatory-activity protein.
    Sticht H; Auer M; Schmitt B; Besemer J; Horcher M; Kirsch T; Lindley IJ; Rösch P
    Eur J Biochem; 1996 Jan; 235(1-2):26-35. PubMed ID: 8631339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the expression of IL-8 receptor A/B by IL-8: possible functions of each receptor.
    Chuntharapai A; Kim KJ
    J Immunol; 1995 Sep; 155(5):2587-94. PubMed ID: 7650389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.